A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Two newer androgen deprivation therapies for late-stage prostate cancer include: Xtandi (enzalutamide) Erleada (apalutamide ... can target and destroy specific cancer cells with fewer side effects ...

It's not uncommon to experience side effects in the first few weeks of taking a new antidepressant. Here's what to look out ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

There is an underdiagnosed condition called statin-induced autoimmune myopathy. It can take years to show up and can be hard ...

Dr. Ritu Salani shared her advice for patients undergoing advanced treatment options for their cervical cancer who are ...

Common Side Effects follows Marshall and Frances, who were lab partners in high school and now share a secret: Marshall has “discovered the world’s greatest medicine, a mushroom that can heal ...

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects. Their work suggests a new target ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...